Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 28Gastric Adenocarcinoma 4Sarcopenia 2Adenocarcinoma 2Recurrence 1Peritoneal Neoplasms 1Patients Who Underwent Gastrectomy With Lymph Node Dissection for Gastric Cancer 1Osteoporosis 1Obesity, Abdominal 1Obesity 1Neoplasms 1Neoplasm Metastasis 1Motor Activity 1Margins of Excision 1Locally Advanced Gastric Carcinoma 1Locally Advanced Gastric Cancer 1Hypertension 1Gastrointestinal Neoplasms 1Esophageal Neoplasms 1Epstein-Barr Virus Infections 1Diabetes Mellitus 1Coitus 1Advanced Gastric Cancer 1

Interventions

Microscopy, Confocal 2Indocyanine Green 2Everolimus 2Dermoscopy 2varlilumab 1Ultrasonography 1Tumor Burden 1Sunitinib 1Simvastatin 1Radiosurgery 1Palliative Care 1Observation 1Neoadjuvant Therapy 1Narrow Band Imaging 1Mastectomy, Segmental 1Interferon alpha-2 1IFL protocol 1Gastrectomy 1Folfox protocol 1Esophagectomy 1Endoscopic Mucosal Resection 1Drug Delivery Systems 1Drug Combinations 1Chemoradiotherapy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Margins of Excision × Gastrectomy × Clear all
NCT02313688 2017-12-11

Length of the Proximal Resection Margin for Siewert-II/Siewert-III Tumors

West China Hospital

Phase NA Unknown
320 enrolled
Gastrointestinal

Margins of Excision, Recurrence, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡